##gff-version 3 Q8NFZ5 UniProtKB Chain 1 429 . . . ID=PRO_0000322583;Note=TNFAIP3-interacting protein 2 Q8NFZ5 UniProtKB Zinc finger 397 429 . . . Note=CCHC NOA-type;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU01142 Q8NFZ5 UniProtKB Region 177 199 . . . Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite Q8NFZ5 UniProtKB Region 289 347 . . . Note=Ubiquitin-binding domain (UBD) Q8NFZ5 UniProtKB Region 372 400 . . . Note=Disordered;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite Q8NFZ5 UniProtKB Coiled coil 29 117 . . . Ontology_term=ECO:0000255;evidence=ECO:0000255 Q8NFZ5 UniProtKB Coiled coil 196 226 . . . Ontology_term=ECO:0000255;evidence=ECO:0000255 Q8NFZ5 UniProtKB Coiled coil 255 340 . . . Ontology_term=ECO:0000255;evidence=ECO:0000255 Q8NFZ5 UniProtKB Compositional bias 177 192 . . . Note=Basic and acidic residues;Ontology_term=ECO:0000256;evidence=ECO:0000256|SAM:MobiDB-lite Q8NFZ5 UniProtKB Binding site 405 405 . . . Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU01142 Q8NFZ5 UniProtKB Binding site 408 408 . . . Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU01142 Q8NFZ5 UniProtKB Binding site 423 423 . . . Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU01142 Q8NFZ5 UniProtKB Binding site 427 427 . . . Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU01142 Q8NFZ5 UniProtKB Modified residue 7 7 . . . Note=Phosphoserine;Ontology_term=ECO:0007744;evidence=ECO:0007744|PubMed:24275569;Dbxref=PMID:24275569 Q8NFZ5 UniProtKB Alternative sequence 1 107 . . . ID=VSP_052701;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039 Q8NFZ5 UniProtKB Natural variant 249 249 . . . ID=VAR_067969;Note=Found in patients with gastrointestinal diffuse large cell lymphoma%3B impairs inhibitory activity on CARD11-induced NF-kappa-B activation. Q->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21266526;Dbxref=dbSNP:rs116129895,PMID:21266526 Q8NFZ5 UniProtKB Natural variant 255 255 . . . ID=VAR_067970;Note=Found in patients with gastrointestinal diffuse large cell lymphoma%3B somatic mutation%3B impairs inhibitory activity on CARD11-induced NF-kappa-B activation and impairs interaction with TNFAIP3. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21266526;Dbxref=dbSNP:rs116412781,PMID:21266526 Q8NFZ5 UniProtKB Natural variant 396 396 . . . ID=VAR_039463;Note=A->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14702039,ECO:0000269|PubMed:15489334;Dbxref=dbSNP:rs2269495,PMID:14702039,PMID:15489334 Q8NFZ5 UniProtKB Mutagenesis 62 62 . . . Note=Reduces phosphorylation. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21784860;Dbxref=PMID:21784860 Q8NFZ5 UniProtKB Mutagenesis 146 146 . . . Note=Reduces phosphorylation%3B reduces CHUK-mediated NF-kappa-B activation. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21784860;Dbxref=PMID:21784860 Q8NFZ5 UniProtKB Mutagenesis 309 310 . . . Note=Abolishes ubiquitin binding. DF->NA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18212736;Dbxref=PMID:18212736 Q8NFZ5 UniProtKB Mutagenesis 313 314 . . . Note=Abolishes ubiquitin binding%3B loss of inhibitory activity on NF-kappa-B activation. ER->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18212736;Dbxref=PMID:18212736 Q8NFZ5 UniProtKB Sequence conflict 153 153 . . . Note=Q->H;Ontology_term=ECO:0000305;evidence=ECO:0000305 Q8NFZ5 UniProtKB Helix 263 273 . . . Ontology_term=ECO:0007829;evidence=ECO:0007829|PDB:5H07 Q8NFZ5 UniProtKB Helix 276 336 . . . Ontology_term=ECO:0007829;evidence=ECO:0007829|PDB:5H07